BELLEVUE, Wash.--(BUSINESS WIRE)--Today, Viome, a longevity company committed to translating scientific advancements into practical and individualized health solutions, has announced the introduction ...

Viome Life Sciences has snatched up Naring Health to build out its personalized nutrition offerings and further its goal to bring at-home diagnostics to the masses. The acquisition of digital health ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Jul 17, 2024 at ...

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...

Inside our bodies lies a flourishing ecosystem of microorganisms. This microbiome of bacteria and viruses has a powerful impact on our health, but the exact nuances of how are still being filled in.

The Series D is an internal round that will be used to drive expansion of Viome's preventative health technologies and help solidify its market position BELLEVUE, Wash., Sept. 10, 2024 /PRNewswire/ -- ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Charlotte Schubert on Nov 10, 2021 ...

Digital health and biotech company Viome Life Sciences has raised $67 million in series C financing. The funding round comes after Viome launched its CancerDetect test as an at-home diagnostic tool ...

At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores. Launched in 2016 ...

Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health ...

First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...